Krane Funds Advisors LLC Atrion Corp Transaction History

Krane Funds Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$605.0 - $763.25 $243,815 - $307,589	-403 Reduced 36.27%	708 $445,000
Q1 2022 May 11, 2022	BUY	$601.4 - $763.0 $56,531 - $71,722	94 Added 9.24%	1,111 $792,000
Q4 2021 Feb 10, 2022	BUY	$650.15 - $802.0 $661,202 - $815,634	1,017 New	1,017 $717,000
Q1 2021 May 14, 2021	SELL	$619.2 - $736.0 $795,052 - $945,024	-1,284 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$576.6 - $672.2 $266,965 - $311,228	463 Added 56.39%	1,284 $825,000
Q3 2020 Nov 13, 2020	SELL	$620.1 - $689.89 $12,402 - $13,797	-20 Reduced 2.38%	821 $0
Q2 2020 Aug 10, 2020	BUY	$610.05 - $713.9 $513,052 - $600,389	841 New	841 $536,000
Q1 2020 May 12, 2020	SELL	$615.5 - $751.4 $595,804 - $727,355	-968 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$688.5 - $846.15 $148,027 - $181,922	215 Added 28.55%	968 $727,000
Q3 2019 Nov 12, 2019	BUY	$722.04 - $840.0 $495,319 - $576,240	686 Added 1023.88%	753 $587,000
Q2 2019 Aug 13, 2019	BUY	$837.83 - $927.0 $56,134 - $62,109	67 New	67 $57,000

114K

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Krane Funds Advisors LLC with notifications on news.